Similar articles

• Factors affecting solubilized dopamine-sensitive adenylate cyclase.

  Marshall AM, Ramwani J, Mishra RK. Marshall AM, et al. Biochem Pharmacol. 1983 Apr 1;32(7):1237-41. doi: 10.1016/0006-2952(83)90277-0. Biochem Pharmacol. 1983. PMID: 6847713
• Inhibition of dopamine-sensitive adenylate cyclase in rat striatum by neuroleptic drugs administered in vivo.

  Nakahara T, Uchimura H, Saito M, Hirano M, Kim JS, Ito M. Nakahara T, et al. J Neurochem. 1978 Nov;31(5):1335-7. doi: 10.1111/j.1471-4159.1978.tb06260.x. J Neurochem. 1978. PMID: 702178 No abstract available.
• Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine or haloperidol.

  Iwatsubo K, Clouet DH. Iwatsubo K, et al. Biochem Pharmacol. 1975 Aug 15;24(16):1499-503. doi: 10.1016/0006-2952(75)90026-x. Biochem Pharmacol. 1975. PMID: 1191307 No abstract available.
• Effect of methadone and dextromoramide on dopamine metabolism: comparison with haloperidol and amphetamine.

  Gessa GL, Tagliamonte A. Gessa GL, et al. Neuropharmacology. 1975 Dec;14(12):913-20. doi: 10.1016/0028-3908(75)90045-3. Neuropharmacology. 1975. PMID: 768800 Review. No abstract available.
• The synapses of the nervous system.

  Manina AA. Manina AA. Int Rev Cytol. 1979;57:345-83. doi: 10.1016/s0074-7696(08)61466-7. Int Rev Cytol. 1979. PMID: 226495 Review. No abstract available.